Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2-positive Metastatic Breast Cancer|Central Nervous System Metastases
Interventions: DRUG: ATEZOLIZUMAB|DRUG: PERTUZUMAB|DRUG: TRASTUZUMAB
Sponsor: Nancy Lin, MD
Collaborators: Genentech, Inc.